Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Study on RNAi technology targeting neurodegenerative diseases

Sirna Therapeutics has announced the publication of preclinical studies evaluating RNA interference-based therapies for a class of inherited neurodegenerative diseases of the central nervous system (CNS) in the current issue of Nature Medicine.

16 Aug 2004

The largest North American breast cancer prevention trial ever undertaken has reached its goal of enrolling 19,000 women

The largest North American breast cancer prevention trial ever undertaken, the Study of Tamoxifen and Raloxifene (STAR), reached its goal of enrolling 19,000 women to the trial in June 2004, a month earlier than originally expected.

13 Aug 2004

What is Telomere crisis?

Telomere crisis is an important early event in the development of breast cancer, and its occurrence can be identified with precision, according to recent findings by a team of scientists at the Department of Energy's Lawrence Berkeley National Laboratory and the University of California at San Francisco.

11 Aug 2004

New treatment strategy for brain cancer

Virginia Commonwealth University Massey Cancer Center researchers have found that combining ionizing radiation with a secreted protein that selectively inhibits tumor cell growth and survival can target cancer cells and leave healthy cells alone, perhaps presenting a new approach for treating the deadliest type of brain tumor.

9 Aug 2004

Total global market for oligonucleotides is likely to grow from USD 340.0 million in 2003 to USD 776.0 million in 2010

Poised on the brink of phenomenal growth, the oligonucleotides market offers a plethora of opportunities to the enterprising investor. Recent analysis by Frost & Sullivan estimates that the total global market for oligonucleotides is likely to grow from USD 340.0 million in 2003 to USD 776.0 million in 2010.

9 Aug 2004

Lack of a gene called LBP-1a in the embryo prevents normal growth of blood vessels in the placenta

The lack of a gene called LBP-1a in the mouse embryo prevents normal growth of blood vessels in the placenta. This finding suggests that a similar defect in humans could play a role in fetal growth retardation, infant mortality and spontaneous abortion.

6 Aug 2004

Physicians offer several promising and unique approaches to brain tumor treatment

An estimated 41,000 new cases of primary brain tumors are expected to be diagnosed in 2004, according to the American Brain Tumor Association.

5 Aug 2004

ASTRO and ACS join to promote cancer survivorship

As part of an initiative to give back to the cancer communities in the cities visited during its annual scientific meetings, the American Society for Therapeutic Radiology and Oncology is partnering with the Atlanta chapter of the American Cancer Society to raise awareness of cancer survivorship.

5 Aug 2004

Successfully cloning mice from an advanced melanoma cell

Nature can reset the clock in certain types of cancer and reverse many of the elements responsible for causing malignancy, reports a research team led by Whitehead Institute Member Rudolf Jaenisch, in collaboration with Lynda Chin from Dana Farber Cancer Institute.

3 Aug 2004

New Drug Application with the U.S. Food and Drug Administration for Tarceva

OSI Pharmaceuticals and Genentech have announced that OSI completed the submission of a New Drug Application with the U.S. Food and Drug Administration for Tarceva (erlotinib HCl),

3 Aug 2004

Recommendation against the use of chemotherapy sensitivity and resistance assays

A new technology assessment from the American Society of Clinical Oncology states that the use of chemotherapy sensitivity and resistance assays (CSRAs) to select chemotherapeutic agents for cancer patients should not be undertaken outside of the clinical trial setting.

3 Aug 2004

Adhering to established guidelines improves survival and reduces the risk of breast cancer

The first study to compare survival between women with breast cancer whose treatment was based on consensus guidelines and those whose treatment was not shows that adhering to established guidelines improves survival and reduces the risk of recurrence.

3 Aug 2004

Alimta receives positive endorsement for lung cancer approval from FDA Advisory Committee

Eli Lilly and Company have announced that the Oncologic Drugs Advisory Committee (ODAC) of the U.S. Food and Drug Administration positively endorsed Alimta® (pemetrexed), an antifolate, for accelerated approval in the second-line treatment of non-small cell lung cancer.

29 Jul 2004

Combination of hormonal therapy, radioactive seed implant and external beam radiation therapy increases chance of cancer cure

High-risk prostate cancer patients who undergo a combination of hormonal therapy, radioactive seed implant (also called brachytherapy) and external beam radiation therapy are shown to have an increased chance of cancer cure

29 Jul 2004

Women with a history of cancer in their family are better off having MRI scans instead of mammograms

New research by Mieke Kriege at the Department of Medical Oncology, Rotterdam Family Cancer Clinic suggests that women with a history of cancer in their family are better off having MRI scans instead of mammogram's.

28 Jul 2004

Light-sensitive probe to help doctors spot breast cancer

A light-sensitive probe is being developed to help doctors spot breast cancer in some of the 70,000 American women each year whose malignancies fail to show up in needle biopsies.

26 Jul 2004

Preliminary tests of the new method, which can detect cancer in a sample with as few as 50 cells

Finding cancer in a tiny drop of body fluid containing relatively few cells now may be possible with a new method of analyzing multiple genes in small samples of DNA, the cellular building blocks of our genetic code.

23 Jul 2004

ImClone quarterly sales reach $71.4 Million

Total revenues for the second quarter of 2004 were $71.5 million as compared with $17.9 million for the second quarter of 2003 and $109.6 million in the first quarter of 2004.

22 Jul 2004

Bladder-sparing treatment shows promise against cancer

For patients with invasive bladder cancer, treatment has typically meant an operation to remove the bladder and nearby organs. This requires up to a week in the hospital and leaves patients with a reconstructed bladder or urostomy bag.

21 Jul 2004

Study finds that physicians help patients quit smoking but could provide more education

Physicians are an important resource in New Jerseyans’ fight to stop smoking, but they can and should become even more effective educators, according to a survey by the Center for State Health Policy (CSHP) at Rutgers, The State University of New Jersey.

21 Jul 2004

Oncology News and Research

Further Reading

Study on RNAi technology targeting neurodegenerative diseases

The largest North American breast cancer prevention trial ever undertaken has reached its goal of enrolling 19,000 women

What is Telomere crisis?

New treatment strategy for brain cancer

Total global market for oligonucleotides is likely to grow from USD 340.0 million in 2003 to USD 776.0 million in 2010

Lack of a gene called LBP-1a in the embryo prevents normal growth of blood vessels in the placenta

Physicians offer several promising and unique approaches to brain tumor treatment

ASTRO and ACS join to promote cancer survivorship

Successfully cloning mice from an advanced melanoma cell

New Drug Application with the U.S. Food and Drug Administration for Tarceva

Recommendation against the use of chemotherapy sensitivity and resistance assays

Adhering to established guidelines improves survival and reduces the risk of breast cancer

Alimta receives positive endorsement for lung cancer approval from FDA Advisory Committee

Combination of hormonal therapy, radioactive seed implant and external beam radiation therapy increases chance of cancer cure

Women with a history of cancer in their family are better off having MRI scans instead of mammograms

Light-sensitive probe to help doctors spot breast cancer

Preliminary tests of the new method, which can detect cancer in a sample with as few as 50 cells

ImClone quarterly sales reach $71.4 Million

Bladder-sparing treatment shows promise against cancer

Study finds that physicians help patients quit smoking but could provide more education

Cancer Research eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News